More Videos
SPECIAL REPORT
MOST SHARED
- US Markets Bracing for Selloff On Worries About Dubai's Debt
- No Thanksgiving Rest for Retailers in Sales Race
- UK's Darling to Downgrade 2009 Growth Forecast
- Attraction of Switzerland to Businesses
- More Asia Executives Resigned to Economy Flights: Survey
- Dubai Debt Delays Revive Fear of Financial Crisis
- ING Prices Share Issue at Hefty Discount
- Oil Falls Toward $74 on Dubai Default Worries
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Revenge of the Gangsta Nerds
- Will TCU See The "Flutie Effect?"
- Retail Earnings and Sales to Improve in Q4: Analyst
- Consumers Catching the Holiday Spirit
- It's Beginning To Look A Lot More Riskless
- Crescenzi: Claims Level Suggests End to Job Losses
- Hedge Funds Take Early Lead in Warren Buffett's 'Big Bet'
- Car Insurance Scofflaws Raise Health Reform Doubt
- Rush Starts as Holiday Shopping Season Revs Up
- US Markets Bracing for Selloff on Dubai Debt Worries
- US Dollar Falls to 14-Year Low Against the Yen
- ING Prices Share Issue at Hefty Discount
- UK's Darling to Downgrade 2009 Growth Forecast
- Tommy Hilfiger's Estate in Conn. Sells for $20 Million
- Cheap Robotic Hamsters Are Holiday's Unlikely Craze
- Fannie Mae to Tighten Lending Standards: Report
PHARMA'S MARKET VIDEO
RSS FEED
Pharma's Market
Text Size 
Pfizer held its shareholder meeting Thursday morning at the Peabody, the historic Memphis hotel where the ducks march through the lobby. I haven't seen the spectacle yet, but I'm told it's quite the scene. 
But it was a smattering of individual investors who were quacking at the meeting here.
One complained about Viagra commercials airing during family-viewing hours and asked Pfizer to follow Eli Lilly's lead to not put Cialis spots on at certain times. Chairman and CEO Jeff Kindler said that as a dad, he's sensitive to that, and wanted to start a dialog with the group the speaker represented.
But a couple of other folks might not have walked away from the microphone as satisfied. They wanted explanations about the declining stock [PFE
Loading...
()
] and assurances it would turn around. At its current price, one PFE exec calculated the stock is paying a 6.5 percent dividend yield. And the handful of investors I talked to before the meeting said the payout is the main reason they're still holding on.
In his opening remarks, Kindler said, "Our progress is not yet reflected in the stock price." You can see his entire prepared statement here.
Reporters weren't allowed inside the meeting. I had to watch it on a closed-circuit feed in a room 20 feet away. I was alone. Meantime, in the ballroom where the meeting was taking place, most of the chairs were empty.
My producer, Ruth, who got to peek in for a minute, counted about a hundred people. Two shareholders said the place would've been jammed if it had been held in New York, where Pfizer is based.
But I did get an exclusive interview with Kindler after he met with the shareholders and his Board and you can watch it here. (See video, above.)
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes